CLMT Related Analyst Ratings
-
RBC Capital Starts Calumet Specialty Products Partners (CLMT) at Outperform
-
Barclays Raises Estimates on Calumet Specialty Products (CLMT); Royal Purple Acquisition Will Impove Cash Flow
-
Barclays Adjusts Estimates on Calumet Specialty Products (CLMT); Acquisition Increases Size and Footprint, But Creates Financing Need
-
Barclays Maintains an 'Equalweight' on Calumet Specialty Products Partners (CLMT); Solid Specialty Margins Likely to Persist
-
Barclays Maintains an 'Equalweight' on Calumet Specialty Products Partners (CLMT): Expect Distribution Growth To Modestly Improve
-
UPDATE - Barclays Initiates Coverage on Calumet Specialty Products Partners (CLMT) with an Equalweight
-
Barclays Starts Calumet Specialty Products Partners (CLMT) at Equalweight
-
Barclays on U.S. Independent Refiners: PC Weekly R&M Margin Analysis
-
Raymond James Downgrades Calumet Specialty (CLMT) to Underperform
-
Deutsche Bank downgrades Calumet Specialty Products Partners LP (CLMT) to Hold
-
Goldman Sachs upgrades Calumet Specialty (CLMT) to Buy
-
Deustche Bank upgrades Calumet Specialty Products Partners LP (CLMT) to Buy
-
S&P Equity Research Downgrades Calumet Specialty Products Partners LP (CLMT) to Hold
-
Goldman Sachs downgrades Calumet Specialty Products (CLMT) to Neutral
-
Raymond James downgrades Calumet Specialty (CLMT) to Market Perform
-
Deutsche Bank downgrades Calumet Specialty Products Partners LP (CLMT) to Hold
-
Goldman Starts CLMT at Outperform, Deutsche Bank Starts at Buy
Back to CLMT Stock Lookup
